• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算华盛顿州 2020 年 3 月至 2023 年 10 月期间新冠后疾病的负担和分布。

Estimating the Burden and Distribution of Post-COVID-19 Condition in Washington State, March 2020-October 2023.

机构信息

Epidemic Intelligence Service, Division of Workforce Development, Centers for Disease Control and Prevention, Atlanta, Georgia.

Washington State Department of Health, 1610 NE 150th St, Shoreline, WA 98155 (

出版信息

Prev Chronic Dis. 2024 Jun 27;21:E47. doi: 10.5888/pcd21.230433.

DOI:10.5888/pcd21.230433
PMID:38935604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11230520/
Abstract

INTRODUCTION

After SARS-CoV-2 infection, some people will experience long-term sequelae known as post-COVID-19 condition (PCC). Although PCC is recognized as a public health problem, estimates of the prevalence of PCC are sparse. We described a framework for estimating the incidence and prevalence of PCC by population subgroups and geography over time in Washington State.

METHODS

We collected data on reported COVID-19 cases and hospitalizations and estimated SARS-CoV-2 infections in Washington State from March 2020 through October 2023. The reported case data were incorporated with parameter estimates from published articles and prevalence estimates from the Household Pulse Survey into a mathematical compartmental model of PCC progression. The model used differential equations to describe how the population of people with PCC moved through the model's various stages. This framework allowed us to integrate data on age group, sex, race and ethnicity, vaccination status, and county to estimate incidence and prevalence of PCC for each subgroup.

RESULTS

Our model indicated that 6.4% (95% CI, 5.9%-6.8%) of all adults in Washington State were experiencing PCC as of October 2023. In addition to temporal differences in PCC prevalence and incidence, we found substantial differences across age groups, race and ethnicity, and sex. Geographic heterogeneity was pronounced, with the highest rates of PCC in central and eastern Washington.

CONCLUSION

Estimation of PCC prevalence is essential for addressing PCC as a public health problem. Responding to PCC will require continued surveillance, research, and dedicated financial and public health action. This analysis, accounting for heterogeneities, highlights disparities in the prevalence, incidence, and distribution of PCC in Washington State and can better guide awareness and response efforts.

摘要

简介

在感染 SARS-CoV-2 后,一些人会出现长期后遗症,即所谓的新冠后疾病(PCC)。尽管 PCC 被认为是一个公共卫生问题,但对其流行率的估计却很少。我们描述了一个框架,用于按人群亚组和地理位置随时间估算华盛顿州 PCC 的发病率和患病率。

方法

我们收集了报告的 COVID-19 病例和住院数据,并估计了 2020 年 3 月至 2023 年 10 月期间华盛顿州的 SARS-CoV-2 感染情况。将报告的病例数据与已发表文章中的参数估计值和家庭脉搏调查中的患病率估计值相结合,纳入到 PCC 进展的数学房室模型中。该模型使用微分方程来描述 PCC 人群如何在模型的各个阶段移动。该框架使我们能够整合年龄组、性别、种族和民族、疫苗接种状况和县的数据,以估算每个亚组的 PCC 发病率和患病率。

结果

我们的模型表明,截至 2023 年 10 月,华盛顿州所有成年人中有 6.4%(95%CI,5.9%-6.8%)患有 PCC。除了 PCC 流行率和发病率的时间差异外,我们还发现了年龄组、种族和民族以及性别的显著差异。地理异质性显著,中东部华盛顿州的 PCC 发病率最高。

结论

估计 PCC 的患病率对于解决 PCC 作为公共卫生问题至关重要。应对 PCC 需要持续监测、研究以及专门的财务和公共卫生行动。这项分析考虑了异质性,突出了华盛顿州 PCC 的患病率、发病率和分布的差异,并能更好地指导意识和应对工作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ada/11230520/4e937cf589f4/PCD-21-E47s05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ada/11230520/7f5a2903d943/PCD-21-E47s01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ada/11230520/36af3f8207e2/PCD-21-E47s02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ada/11230520/a43bed935459/PCD-21-E47s03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ada/11230520/fb0345035c45/PCD-21-E47s04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ada/11230520/4e937cf589f4/PCD-21-E47s05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ada/11230520/7f5a2903d943/PCD-21-E47s01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ada/11230520/36af3f8207e2/PCD-21-E47s02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ada/11230520/a43bed935459/PCD-21-E47s03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ada/11230520/fb0345035c45/PCD-21-E47s04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ada/11230520/4e937cf589f4/PCD-21-E47s05.jpg

相似文献

1
Estimating the Burden and Distribution of Post-COVID-19 Condition in Washington State, March 2020-October 2023.估算华盛顿州 2020 年 3 月至 2023 年 10 月期间新冠后疾病的负担和分布。
Prev Chronic Dis. 2024 Jun 27;21:E47. doi: 10.5888/pcd21.230433.
2
Tracking the burden, distribution, and impact of Post-COVID conditions in diverse populations for children, adolescents, and adults (Track PCC): passive and active surveillance protocols.追踪不同人群中儿童、青少年和成年人的新冠后状况(Track PCC)负担、分布和影响:被动和主动监测方案。
BMC Public Health. 2024 Aug 29;24(1):2345. doi: 10.1186/s12889-024-19772-4.
3
An ecological comparison to inspect the aftermath of post COVID-19 condition in Italy and the United States.对意大利和美国新冠疫情后状况进行生态比较。
Sci Rep. 2024 Aug 21;14(1):19407. doi: 10.1038/s41598-024-70437-z.
4
Incidence of SARS-CoV-2 Infection, Emergency Department Visits, and Hospitalizations Because of COVID-19 Among Persons Aged ≥12 Years, by COVID-19 Vaccination Status - Oregon and Washington, July 4-September 25, 2021.2021 年 7 月 4 日至 9 月 25 日,≥12 岁人群中 COVID-19 疫苗接种状况与 SARS-CoV-2 感染、因 COVID-19 前往急诊就诊和住院的关系 - 俄勒冈州和华盛顿。
MMWR Morb Mortal Wkly Rep. 2021 Nov 19;70(46):1608-1612. doi: 10.15585/mmwr.mm7046a4.
5
Interplay of demographics, geography and COVID-19 pandemic responses in the Puget Sound region: The Vashon, Washington Medical Reserve Corps experience.人口统计学、地理位置和 COVID-19 大流行应对措施在普吉特海湾地区的相互作用:华盛顿州沃申市医疗后备队的经验。
PLoS One. 2023 Aug 16;18(8):e0274345. doi: 10.1371/journal.pone.0274345. eCollection 2023.
6
Psychiatric Symptoms, Treatment Uptake, and Barriers to Mental Health Care Among US Adults With Post-COVID-19 Condition.新冠后状况的美国成年人的精神症状、治疗接受情况及心理健康护理障碍
JAMA Netw Open. 2024 Apr 1;7(4):e248481. doi: 10.1001/jamanetworkopen.2024.8481.
7
Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.尼马曲韦联合治疗与新冠病毒感染后综合征风险的关联。
JAMA Intern Med. 2023 Jun 1;183(6):554-564. doi: 10.1001/jamainternmed.2023.0743.
8
Prevalence of Post-COVID conditions among Mexican COVID-19 survivors: a nationwide cross-sectional study.墨西哥 COVID-19 幸存者中新冠后疾病的流行情况:一项全国性的横断面研究。
BMC Public Health. 2024 Jun 28;24(1):1729. doi: 10.1186/s12889-024-19274-3.
9
Prevalence and Characteristics Associated With Post-COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults.非住院青少年和年轻成年人中与新冠后状况相关的流行率和特征。
JAMA Netw Open. 2023 Mar 1;6(3):e235763. doi: 10.1001/jamanetworkopen.2023.5763.
10
Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).不同疫情波次下住院 SARS-CoV-2 阳性儿童和青少年及对照者的新冠后疾病发生率和发病情况:莫斯科(StopCOVID)的分层暴露前瞻性队列研究
BMC Med. 2024 Feb 1;22(1):48. doi: 10.1186/s12916-023-03221-x.

本文引用的文献

1
Risk of New-Onset Long COVID Following Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2: A Community-Based Cohort Study.严重急性呼吸综合征冠状病毒2再次感染后新发长期新冠的风险:一项基于社区的队列研究。
Open Forum Infect Dis. 2023 Oct 5;10(11):ofad493. doi: 10.1093/ofid/ofad493. eCollection 2023 Nov.
2
COVID-Specific Long-term Sequelae in Comparison to Common Viral Respiratory Infections: An Analysis of 17 487 Infected Adult Patients.与常见病毒性呼吸道感染相比,新冠病毒感染后的特定长期后遗症:对17487名成年感染患者的分析
Open Forum Infect Dis. 2022 Dec 21;10(1):ofac683. doi: 10.1093/ofid/ofac683. eCollection 2023 Jan.
3
Long COVID: major findings, mechanisms and recommendations.
长新冠:主要发现、机制和建议。
Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.
4
Machine learning identifies long COVID patterns from electronic health records.机器学习从电子健康记录中识别长新冠模式。
Nat Med. 2023 Jan;29(1):47-48. doi: 10.1038/s41591-022-02130-5.
5
Mortality in the United States, 2021.2021年美国的死亡率
NCHS Data Brief. 2022 Dec(456):1-8.
6
Ascertainment rate of SARS-CoV-2 infections from healthcare and community testing in the UK.英国医疗卫生和社区检测中 SARS-CoV-2 感染的检出率。
J Theor Biol. 2023 Feb 7;558:111333. doi: 10.1016/j.jtbi.2022.111333. Epub 2022 Nov 5.
7
Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study.苏格兰长新冠研究中确诊病例与匹配对照组的结局。
Nat Commun. 2022 Oct 12;13(1):5663. doi: 10.1038/s41467-022-33415-5.
8
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.估计 2020 年和 2021 年有症状 COVID-19 后持续性疲劳、认知和呼吸症状群个体在全球的比例。
JAMA. 2022 Oct 25;328(16):1604-1615. doi: 10.1001/jama.2022.18931.
9
Association between BNT162b2 vaccination and reported incidence of post-COVID-19 symptoms: cross-sectional study 2020-21, Israel.BNT162b2疫苗接种与新冠后症状报告发病率之间的关联:2020 - 2021年以色列横断面研究
NPJ Vaccines. 2022 Aug 26;7(1):101. doi: 10.1038/s41541-022-00526-5.
10
Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and Adolescents.儿童和青少年 SARS-CoV-2 感染后后遗症的临床特征和负担。
JAMA Pediatr. 2022 Oct 1;176(10):1000-1009. doi: 10.1001/jamapediatrics.2022.2800.